GRN | SGOL | GRN / SGOL | |
Gain YTD | 1.657 | 11.856 | 14% |
Net Assets | 25M | 4.22B | 1% |
Total Expense Ratio | N/A | N/A | - |
Turnover | N/A | N/A | - |
Yield | 0.00 | 0.00 | - |
Fund Existence | 5 years | 15 years | - |
SGOL | |
---|---|
RSI ODDS (%) | 3 days ago66% |
Stochastic ODDS (%) | N/A |
Momentum ODDS (%) | N/A |
MACD ODDS (%) | N/A |
TrendWeek ODDS (%) | 3 days ago83% |
TrendMonth ODDS (%) | 3 days ago81% |
Advances ODDS (%) | 5 days ago80% |
Declines ODDS (%) | N/A |
BollingerBands ODDS (%) | 3 days ago71% |
Aroon ODDS (%) | 3 days ago81% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FPHAX | 27.37 | 0.29 | +1.07% |
Fidelity Select Pharmaceuticals Port | |||
QBDSX | 8.03 | 0.01 | +0.12% |
Quantified Managed Income Investor | |||
JMNCX | 12.68 | -0.10 | -0.78% |
JPMorgan Research Market Neutral C | |||
SUWIX | 34.91 | -0.68 | -1.91% |
DWS Core Equity Inst | |||
PSMPX | 5.47 | -2.66 | -32.69% |
Penn Capital Mid Cap Core Inst |